Only a quarter of Pfizer’s COVID-19 treatment orders will go to developing countries--Oxfam

Just a quarter of Pfizer’s COVID-19 treatment orders will go to developing countries | Oxfam International

Some nations could be paying ten times the price of Paxlovid’s generic equivalent, as WHO chief calls for treatment access to battle acute and long COVID-19

Rich countries have secured almost three times as many courses of a World Health Organisation (WHO)-recommended COVID-19 medicine, Pfizer’s Paxlovid, according to new analysis from Oxfam and the People’s Vaccine Alliance.

...